| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-05 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |